SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-19-034640
Filing Date
2019-06-10
Accepted
2019-06-10 18:20:44
Documents
2
Period of Report
2019-06-07

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3904
2 EX-24 ex-24.htm EX-24 7281
  Complete submission text file 0001104659-19-034640.txt   12377
Mailing Address
Business Address
JEFFS ROGER (Reporting) CIK: 0001231615 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37635 | Film No.: 19889564

Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Issuer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations